A school-based malaria screening and treatment program in rural coastal Kenya had no benefits on the health and education of school children, according to a study in PLOS Medicine.
The study, led by the London School of Hygiene & Tropical Medicine, included 5,233 children from 101 government schools. Read more
On the back of the publication of a landmark report on mental health at the World Innovation Summit for Health (WISH), Lord Nigel Crisp, former Chief Executive of the National Health Services, yesterday addressed the House of Lords to ask the government what is their response to the recommendation for improving mental health globally made at the summit. Read more
A report highlighting a range of innovations to tackle global mental health problems has been presented at the World Innovation Summit for Health in Doha, Qatar.
‘Transforming Lives, Enhancing Communities: Innovations in Mental Health’, a report by the Mental Health Working Group 2013, was discussed at the global summit by co-author Professor Vikram Patel from the London School of Hygiene & Tropical Medicine. Read more
Children with disabilities are being denied an education across the developing world, according to a new report from the London School of Hygiene & Tropical Medicine and the child rights organisation, Plan International.
Research – led by Dr Hannah Kuper, Director of the School’s International Centre for Evidence in Disability – found that children with disabilities are 10 times less likely to attend school than children without disabilities. Even when children with disabilities do access education, they often fall behind their peers. Read more
Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission, according to a study published today in Lancet Infectious Diseases by London School of Hygiene & Tropical Medicine researchers.
Primaquine is one of the few antimalarial drugs that targets the transmission stages of the malaria parasite, the gametocytes, and is therefore considered to be an important tool for malaria elimination. Read more
Call for investment in environmental strategies to eliminate the most common cause of infectious blindness
temperatures and low rainfall are important factors which influence the occurrence and severity of the active stages of trachoma – the most common cause of infectious blindness – according to a new study published in PLOS Neglected Tropical Diseases
. Read more
Early results from a clinical drug trial of a new four-month treatment for tuberculosis (TB) indicate that it is well tolerated, but overall could not be considered as an alternative to current six-month standard treatment. The study – one of the first in 35 years – was presented at the 44th Union World Conference on Lung Health in Paris on 3 November by researchers from the London School of Hygiene & Tropical Medicine on behalf of the Gatifloxacin for TB team. Read more
Experts from the School’s Malaria Centre and the ACT Consortium recently joined hundreds of researchers, activists, health workers, public health officials and policymakers at the Multilateral Initiative on Malaria (MIM) conference in Durban, South Africa. Read more
This month Wendy Macdowall, Maggie Davies, and Liza Cragg publish the second edition of their book, Health Promotion Theory.
Described as “a readable and engaging overview of health promotion theory and practice from a public health perspective”, the book explores the origins and development of health promotion.
Aimed at both students and practitioners, it highlights the philosophical, ethical and political debates that influence health promotion today while also explaining the theories, frameworks and methodologies that help us understand public health problems and develop effective health promotion responses. Read more
Malaria experts comment on the latest findings from the RTS,S vaccine trial
Experts from the London School of Hygiene & Tropical Medicine have welcomed the latest interim results of a major international study being carried out in Africa.
Results from the Phase III trial show that the RTS,S vaccine almost halved the number of malaria cases in young children (aged 5-17 months at first vaccination) and reduced by around a quarter the malaria cases in infants (aged 6-12 weeks at first vaccination) after 18 months of follow-up. Read more